Sickle Cell Disease
811
133
186
410
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
173 trials with published results (21%)
Research Maturity
410 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.5%
85 terminated out of 811 trials
82.8%
-3.7% vs benchmark
11%
90 trials in Phase 3/4
42%
173 of 410 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 410 completed trials
Clinical Trials (811)
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell Disorder
Feasibility and Acceptability of Amani
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
Acupressure in Patients With Sickle Cell Disease
Integrative Medicine in Pain Management in Sickle Cell Disease
Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
Blood Sampling for Research Related to Sickle Cell Disease